Beam Therapeutics Inc header image

Beam Therapeutics Inc

BEAM

Equity

ISIN null / Valor 50337226

NASDAQ (2026-08-07)
USD 27.48+0.84%

Beam Therapeutics Inc
UMushroom community rating:

star star star star star
4.00 4 votes No rating yet
NegativeNeutralPositive

About company

Beam Therapeutics Inc is a biotechnology company focused on developing innovative gene editing technologies to treat a wide range of genetic diseases. The company's delivery strategy involves utilizing a suite of clinically validated technologies, including electroporation, nonviral, and viral delivery modalities, to efficiently and precisely edit genes. Beam Therapeutics Inc aims to revolutionize the field of gene editing by providing novel solutions for patients with genetic disorders.

Summarized from source with an LLMView SourceSector: Technology

Latest Results ():

Summarized from source with an LLMView Source

Key figures

53.9%1Y
7.60%3Y
-74.6%5Y

Performance

73.7%1Y
73.6%3Y
74.5%5Y

Volatility

Market cap

2838 M

Market cap (USD)

Daily traded volume (Shares)

1,324,280

Daily traded volume (Shares)

1 day high/low

26.41 / 24.77

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

4.00

4 votes
Performance:
starstarstarstarstar
3.75
Innovation:
starstarstarstarstar
3.25
Society:
starstarstarstarstar
3.00
Nature:
starstarstarstarstar
2.75
Fabio Kull
Switzerland, 30 Oct 2025
star star star star star
promising biotech company focused on precise gene editing. The stock is innovative but risky
Carlos Mayes
UK, 21 Oct 2025
star star star star star
Strong growth currently
Ben Marshall
UK, 21 Oct 2025
star star star star star
Currently performing very well however has potential to fall off completely soon

EQUITIES OF THE SAME SECTOR

Alten
Alten Alten Valor: 991814
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.40%EUR 75.70
EnerSys Inc
EnerSys Inc EnerSys Inc Valor: 1865089
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.28%USD 191.72
Kyndryl Holdings Incorporation
Kyndryl Holdings Incorporation Kyndryl Holdings Incorporation Valor: 114282708
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.21%USD 14.02
Semtech Corp
Semtech Corp Semtech Corp Valor: 969640
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
3.44%USD 139.42
JinkoSolar Holding Co Ltd
JinkoSolar Holding Co Ltd JinkoSolar Holding Co Ltd Valor: 11035900
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
5.13%USD 17.01
Chegg Inc
Chegg Inc Chegg Inc Valor: 22152564
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
4.22%USD 0.92
Apple Inc
Apple Inc Apple Inc Valor: 908440
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.29%USD 313.33
Microsoft Corp
Microsoft Corp Microsoft Corp Valor: 951692
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.03%USD 499.99
Alphabet Inc
Alphabet Inc Alphabet Inc Valor: 29798540
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.96%USD 354.30
Vetoquinol SA
Vetoquinol SA Vetoquinol SA Valor: 1393361
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.82%EUR 72.60